Mangalam Drugs and Organics Ltd

MANGALAM
NSE· Healthcare
₹26.99
-0.43 (-1.57%)
52W Low · ₹22.8052W High · ₹93.08
Near 52W Low
Market Cap
₹45.11L Cr
Volume
6.4K
Prev Close
₹27.22
ISIN
INE584F01014

Orion Score

Fundamentals-based quality & risk · not a recommendation

13/100
Avoid

Mangalam Drugs and Organics Ltd scores 13/100 (Avoid) on the Orion Score — poor business quality (13), poor growth (8) and poor balance-sheet safety (17). A fundamentals-based quality & risk score, not a buy/sell recommendation.

Quality
13
Growth
8
Safety
17
Value
—

Full Orion analysis

Risk checks

  • Low interest cover (-2.0x) on real debt — distress risk
  • Micro-cap (~Rs 45 cr) — limited reliability/liquidity

Forensic accounting

Piotroski F 2/9Altman Z Safe(3.88)Beneish M Clean(-3.10)

Piotroski F = fundamental health (0–9, higher is better) · Altman Z = bankruptcy / distress risk · Beneish M = earnings-manipulation check

Technical / Momentum

Price Trend

39/100

Neutral

Technical momentum companion — separate from the fundamentals-based Orion Score.

Unlock with Pro

Upgrade →

VestAI Stock Score

VALUATION
Moderate
D/E 1.09x — manageable leverage
QUALITY
Low Quality
ROCE -28.0% — poor capital efficiency
MOMENTUM
Neutral
RSI 44.3 — consolidating

Price Chart

SMA 20
SMA 50
SMA 200

Key Fundamentals

Q4 FY2026

P/E Ratio
—
ROCE
-27.98%
ROE (1Y)
-35.23%
D/E Ratio
1.09x
OPM
-15.27%
TTM EPS
₹-28.05
Dividend Yield
0.00%
Qtrly Sales
₹67.29 Cr
Qtrly Profit
₹-13.42 Cr

Technical Signals

Quarterly Results

Revenue & Profit in ₹ Crores

Revenue Net Profit
QuarterRevenueNet ProfitOPMEPS
Q4 2026₹67.29₹-13.42-15.3%₹-8.48
Q3 2026₹58.38₹-9.84-10.1%₹-6.21
Q2 2026₹49.26₹-7.35-15.2%₹-4.64
Q1 2026₹57.21₹-13.8-15.6%₹-8.72
Q4 2025₹72.78₹0.067.1%₹0.04

Annual P&L

Revenue & Profit in ₹ Crores (Yearly)

Revenue Net Profit
YearRevenueNet ProfitEBITDAOPM
FY 2026₹232.13₹-44.4₹-14.14-14.3%
FY 2025₹317.58₹6.72₹36.335.8%
FY 2024₹365.49₹-9.07₹13.990.3%
FY 2023₹365.97₹1.27₹22.124.0%

Peer Comparison — Healthcare

Top companies in the same sector by market cap

CompanyMkt CapP/EROCEROED/EOPM
MANGALAM ★₹45 Cr—-27.98%-35.23%1.09x-15.27%
SUNPHARMA₹4,27,609 Cr37.3215.73%14.72%0.06x18.90%
MAXHEALTH₹95,110 Cr66.2111.94%14.33%0.32x22.56%
AUROPHARMA₹88,148 Cr25.3912.55%9.93%0.21x15.11%
ASTERDM₹68,390 Cr104.348.93%10.07%0.46x13.98%
ABBOTINDIA₹59,509 Cr38.2836.31%34.46%0.04x27.01%

Balance Sheet

All values in ₹ Crores

MetricFY 2025FY 2024FY 2023FY 2022
Total Assets₹366.42₹333.7₹359.63₹328.43
Equity₹148.98₹135.79₹151.96₹150.56
Total Debt₹96.23₹105.64₹88.55₹87.9
Cash₹2.59₹1.18₹2.68₹1.95
Net Debt₹85.65₹93.92₹71.91₹76.87
Working Capital₹7.38₹11.94₹41.23₹54.92

Shareholding Pattern

Q1 FY2027

Promoter
53.3%
FII
0%
DII
0%
Public
46.7%

Quarter-over-Quarter Trend

QuarterPromoterFIIDIIPublic
Q1 FY202753.3% ↑0% ↓0%46.7% ↓
Q3 FY202635.64% ↓0.13% ↑—64.22% ↑
Q2 FY202650.3%0.11% ↓—49.57% ↑
Q1 FY202650.3%0.53% ↑—49.16% ↓
Q4 FY202550.3%0.47% ↑—49.23% ↓
Q3 FY202550.3%0.11%—49.58%
Q2 FY202550.3% ↓0.11% ↓—49.58% ↑
Q1 FY202550.31%0.21%—49.47%

Corporate Actions

No recent corporate actions

Analyse MANGALAM with Orion AI

Ask: "Is Mangalam Drugs and Organics Ltd stock a good buy right now?" — Get RSI, MACD, ROCE + AI recommendation

Analyse with Orion

Want more insights like this?

Get free stock analysis, market insights, and investment ideas delivered to your inbox.

No spam. Unsubscribe anytime.

About Mangalam Drugs and Organics Ltd (MANGALAM) Stock

Mangalam Drugs and Organics Ltd is listed on the NSE under the Healthcare sector, Pharmaceuticals industry. ISIN: INE584F01014. Track live share price, technical analysis, RSI, MACD, PE ratio, and smart money holdings on VestAI — India's AI-powered stock analysis platform.